COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 188 filers reported holding COHERUS BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $248,241 | -36.5% | 58,136 | +1.7% | 0.00% | -50.0% |
| Q1 2023 | $391,111 | +114259.9% | 57,180 | +32.5% | 0.00% | -20.0% |
| Q4 2022 | $342 | -99.9% | 43,151 | -6.6% | 0.01% | -28.6% |
| Q3 2022 | $444,000 | +32.9% | 46,190 | +0.2% | 0.01% | +40.0% |
| Q2 2022 | $334,000 | -42.7% | 46,115 | +2.1% | 0.01% | -37.5% |
| Q1 2022 | $583,000 | -20.5% | 45,183 | -1.7% | 0.01% | -11.1% |
| Q4 2021 | $733,000 | -2.9% | 45,949 | -2.1% | 0.01% | 0.0% |
| Q3 2021 | $755,000 | +9.9% | 46,957 | -5.5% | 0.01% | +12.5% |
| Q2 2021 | $687,000 | -1.7% | 49,678 | +3.8% | 0.01% | -11.1% |
| Q1 2021 | $699,000 | -21.0% | 47,858 | -6.0% | 0.01% | -18.2% |
| Q4 2020 | $885,000 | -17.8% | 50,909 | -13.3% | 0.01% | -26.7% |
| Q3 2020 | $1,077,000 | +25.1% | 58,748 | +21.9% | 0.02% | +7.1% |
| Q2 2020 | $861,000 | – | 48,183 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |